Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genfit SA (FR:GNFT)
PARIS:GNFT
Holding FR:GNFT?
Track your performance easily
GNFT Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.90 - €5.86
Previous Close€4.1
Volume11.42K
Average Volume (3M)313.85K
Market Cap
€204.54M
Enterprise Value€196.93M
Total Cash (Recent Filing)$77.79M
Total Debt (Recent Filing)$70.18M
Price to Earnings (P/E)9.1
Beta1.02
Next Earnings
Apr 10, 2025EPS Estimate
-€0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding49,834,983
10 Day Avg. Volume369,114
30 Day Avg. Volume313,845
Standard Deviation0.20
R-Squared0.09
Alpha0.00264
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)7.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.89
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.40Price Target Upside111.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.02% Mutual Funds
― Other Institutional Investors
99.97% Public Companies and
Individual Investors
GNFT FAQ
What was Genfit SA’s price range in the past 12 months?
Genfit SA lowest stock price was €2.90 and its highest was €5.86 in the past 12 months.
What is Genfit SA’s market cap?
Currently, no data Available
When is Genfit SA’s upcoming earnings report date?
Genfit SA’s upcoming earnings report date is Apr 10, 2025 which is in 134 days.
How were Genfit SA’s earnings last quarter?
Genfit SA released its earnings results on Sep 19, 2024. The company reported €0.53 earnings per share for the quarter, beating the consensus estimate of €0.31 by €0.22.
Is Genfit SA overvalued?
According to Wall Street analysts Genfit SA’s price is currently Undervalued.
Does Genfit SA pay dividends?
Genfit SA does not currently pay dividends.
What is Genfit SA’s EPS estimate?
Genfit SA’s EPS estimate is -€0.42.
How many shares outstanding does Genfit SA have?
Genfit SA has 49,992,786 shares outstanding.
What happened to Genfit SA’s price movement after its last earnings report?
Genfit SA reported an EPS of €0.53 in its last earnings report, beating expectations of €0.31. Following the earnings report the stock price went up 10.23%.
Which hedge fund is a major shareholder of Genfit SA?
Currently, no hedge funds are holding shares in FR:GNFT
---
Genfit Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.95%
12-Months-Change
Fundamentals
Return on Equity
26.13%
Trailing 12-Months
Asset Growth
-1.36%
Trailing 12-Months
Company Description
Genfit SA
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné and Bart Staels on September 1999 and is headquartered in Loos, France.
---
GNFT Earnings Call
Q2 2023
0:00 / 0:00
---
GNFT Stock 12 Month Forecast
Average Price Target
€8.40
▲(111.05% Upside)
Technical Analysis
Genfit
―
Adaptimmune Therapeutics
―
Arrowhead Pharmaceuticals
―
BioCryst
―
Crispr Therapeutics AG
―
Best Analysts Covering GNFT
1 Year
1 Year Success Rate
9/16 ratings generated profit
1 Year Average Return
+8.79%
reiterated a buy rating 13 days ago
Copying Justine Telliez's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of +8.79% per trade.
---